Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
The University of Texas Health Science Center, Houston · NCT07182045
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- September 18, 2025
- Record last updated
- May 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
Being studied: Temporary clamping of uterine and ovarian vessels
Conditions: Myoma; Surgery
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/>5cm or
- Patients undergoing minimally invasive Myomectomy with =/> 5 fibroids
Exclusion Criteria
- Pregnancy,
- Age \<18yo,
- Patients undergoing concomitant surgery such as endometriosis surgery,
- Suspected malignancy
Recruiting US locations
Memorial Hermann Hospital
Houston, TX 77030
Site contact: Randa Jalloul, MD · 713-486-7700 · randa.j.jalloul@uth.tmc.edu
Study contacts (from the official record)
- Randa Jalloul, MD · 3137128603 · randa.j.jalloul@uth.tmc.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75